or Try an Advanced Search...

    Transplantation Stocks List

    Symbol Grade Name % Change
    JAZZ B Jazz Pharmaceuticals plc 1.25
    JSPR C Jasper Therapeutics, Inc 0.96
    MESO C Mesoblast Limited -0.69
    SABS D SAB Biotherapeutics, Inc. 1.95
    INAB D IN8bio, Inc. -0.75
    PLUR D Pluri Inc. 4.26
    OPT F Opthea Limited 0.96
    TCRX F TScan Therapeutics, Inc. 8.12
    TMDX F TransMedics Group, Inc. -4.16
    CVM F Cel-Sci Corporation -1.44
    View As Page of Charts
    Related Industries: Biotechnology Medical Devices
    Related Stock Lists: Biotechnology Cancer Immunology Life Sciences Medicine Stem Cell Biopharmaceutical Immune System Immunotherapy Antibodies Clinical Medicine Diabetes Graft Versus Host Disease Host Disease Infectious Diseases Rheumatoid Arthritis Solid Tumors Surgery Transplantation Medicine Actinides

    Related ETFs - A few ETFs which own one or more of the above listed Transplantation stocks.

    Symbol Grade Name Weight
    XPH B SPDR S&P Pharmaceuticals ETF 3.94
    PJP C PowerShares Dynamic Pharmaceuticals 3.62
    FTXH C First Trust Nasdaq Pharmaceuticals ETF 3.45
    YOLO F AdvisorShares Pure Cannabis ETF 3.28
    TOKE F Cambria Cannabis ETF 3.15
    View all Transplantation ETFs...
    Compare ETFs
    Compare XPH to FTXH Compare XPH to TOKE Compare YOLO to TOKE

        Transplantation Stocks Recent News

        Date Stock Title
        Nov 23 TMDX 2 Hypergrowth Stocks That Are Screaming Buys in November
        Nov 22 JAZZ ChromaDex Corporation (CDXC) Hits Fresh High: Is There Still Room to Run?
        Nov 22 JAZZ Jazz Pharmaceuticals price target lowered to $163 from $166 at Piper Sandler
        Nov 22 TMDX Jim Cramer on TransMedics Group, Inc. (TMDX): ‘I Don’t Know How You Can Really Make A Lot Of Money In That Business, Frankly’
        Nov 21 JAZZ Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
        Nov 21 JAZZ Jazz and Zymeworks announce FDA approval of cancer therapy Ziihera
        Nov 21 JAZZ Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera® (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)
        Nov 20 TMDX Jim Cramer Likes Devon Energy, But Calls Another Stock 'Far Superior'
        Nov 19 TMDX TransMedics to Participate in the Piper Sandler 36th Annual Healthcare Conference
        Nov 19 JAZZ Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference
        Nov 19 TMDX TransMedics: Long-Term Thesis Hasn't Changed At All
        Nov 19 JAZZ Should Value Investors Buy Jazz Pharmaceuticals (JAZZ) Stock?
        Nov 19 JAZZ Silver Ring Value Partners: Jazz Pharmaceuticals (JAZZ) Is a “High Uncertainty With Low Risk” Investment
        Nov 18 TMDX Navigating 11 Analyst Ratings For TransMedics Gr
        Nov 18 JAZZ Jazz Pharmaceuticals: High Uncertainty, Low Risk
        Nov 18 JAZZ Is Jazz Pharmaceuticals plc (JAZZ) the Best Immunotherapy Stock to Buy Now?
        Related Industries: Biotechnology Medical Devices
        Related Stock Lists: Biotechnology Cancer Medicine Life Sciences Stem Cell Clinical Medicine Host Disease Immune System Immunology Biopharmaceutical Bone Bone Marrow Diabetes Graft Versus Host Disease Immunotherapy Organ Transplant Organ Transplantation Rheumatoid Arthritis Solid Tumors Surgery
        Transplantation

        Browse All Tags